EPHB3 and Familial prostate cancer: EphrinB2 ligand expressed on prostate CAFs can interact with the EphB3/4 receptors on the surface of prostate cancer cells to activate Cdc42 signaling and increase the invasive potential of PC-3 cells in vitro [215].